(Q36203074)

12 August 2017

1 reference

title

Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications (English)

1 reference

12 August 2017

1 reference

1 reference

Guido Boerrigter

1

1 reference

PubMed ID

16036034

12 August 2017

John C Burnett

series ordinal

2

1 reference

12 August 2017

1 September 2004

1 reference

Current heart failure reports

12 August 2017

1 reference

12 August 2017

1

1 reference

12 August 2017

3

1 reference

12 August 2017

113-120

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-004-0020-9

12 August 2017

0 references

cites work

Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-004-0020-9

Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-004-0020-9

Nonpharmacologic care of heart failure: counseling, dietary restriction, rehabilitation, treatment of sleep apnea, and ultrafiltration

21 January 2018

1 reference

12 December 2020

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

1 reference

12 December 2020

Keeping your patient with heart failure safe: a review of potentially dangerous medications

1 reference

12 December 2020

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

12 December 2020

Adenosine formed by 5'-nucleotidase mediates tubuloglomerular feedback.

1 reference

12 December 2020

Sparing a little may save a lot: lessons from the Studies of Left Ventricular Dysfunction (SOLVD).

1 reference

12 December 2020

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

1 reference

12 December 2020

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

1 reference

12 December 2020

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

12 December 2020

Usefulness of carperitide for the treatment of refractory heart failure due to severe acute myocardial infarction

1 reference

12 December 2020

Diuretic therapy and resistance in congestive heart failure

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

1 reference

12 December 2020

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

1 reference

12 December 2020

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

1 reference

12 December 2020

Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy

1 reference

12 December 2020

Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure

1 reference

12 December 2020

A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

1 reference

12 December 2020

B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure

1 reference

12 December 2020

Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients

1 reference

12 December 2020

Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure

1 reference

12 December 2020

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

12 December 2020

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

1 reference

12 December 2020

Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects

1 reference

12 December 2020

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues

1 reference

12 December 2020

Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(-)-cotransporter abundance: role of aldosterone

1 reference

12 December 2020

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure

1 reference

12 December 2020

Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure

1 reference

12 December 2020

The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.

1 reference

12 December 2020

Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure

1 reference

12 December 2020

The prognostic importance of different definitions of worsening renal function in congestive heart failure

1 reference

12 December 2020

Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.

1 reference

12 December 2020

Hormones and hemodynamics in heart failure

1 reference

12 December 2020

Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure

1 reference

12 December 2020

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

12 December 2020

Sustained benefit from ultrafiltration in moderate congestive heart failure.

1 reference

12 December 2020

10.1007/S11897-004-0020-9

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16036034